• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COMT 和 MAO-B 基因变异与精神分裂症患者阴性症状的关联。

The Associations between COMT and MAO-B Genetic Variants with Negative Symptoms in Patients with Schizophrenia.

机构信息

Department of Psychiatry and Psychological Medicine, University Hospital Centre Zagreb, 10 000 Zagreb, Croatia.

Ruder Boskovic Institute, 10 000 Zagreb, Croatia.

出版信息

Curr Issues Mol Biol. 2021 Jul 8;43(2):618-636. doi: 10.3390/cimb43020045.

DOI:10.3390/cimb43020045
PMID:34287249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8928957/
Abstract

Negative symptoms of schizophrenia, including anhedonia, represent a heavy burden on patients and their relatives. These symptoms are associated with cortical hypodopamynergia and impaired striatal dopamine release in response to reward stimuli. Catechol-O-methyltransferase (COMT) and monoamine oxidase type B (MAO-B) degrade dopamine and affect its neurotransmission. The study determined the association between rs4680 and rs4818, rs1799836 and rs6651806 polymorphisms, the severity of negative symptoms, and physical and social anhedonia in schizophrenia. Sex-dependent associations were detected in a research sample of 302 patients with schizophrenia. In female patients with schizophrenia, the presence of the G allele or GG genotype of rs4680 and rs4818, as well as GG haplotype rs4818-rs4680, which were all related to higher COMT activity, was associated with an increase in several dimensions of negative symptoms and anhedonia. In male patients with schizophrenia, carriers of the rs1799836 A allele, presumably associated with higher MAO-B activity, had a higher severity of alogia, while carriers of the A allele of the rs6651806 had a higher severity of negative symptoms. These findings suggest that higher dopamine degradation, associated with COMT and MAO-B genetic variants, is associated with a sex-specific increase in the severity of negative symptoms in schizophrenia patients.

摘要

精神分裂症的阴性症状,包括快感缺失,给患者及其亲属带来了沉重的负担。这些症状与皮质下多巴胺能减退和纹状体多巴胺释放对奖励刺激的反应受损有关。儿茶酚-O-甲基转移酶(COMT)和单胺氧化酶 B(MAO-B)降解多巴胺并影响其神经传递。该研究确定了 rs4680 和 rs4818、rs1799836 和 rs6651806 多态性与精神分裂症阴性症状严重程度以及身体和社交快感缺失之间的关系。在 302 名精神分裂症患者的研究样本中检测到了性别依赖性关联。在女性精神分裂症患者中,rs4680 和 rs4818 的 G 等位基因或 GG 基因型的存在,以及与 COMT 活性更高相关的 rs4818-rs4680 GG 单倍型,与阴性症状和快感缺失的多个维度的增加有关。在男性精神分裂症患者中,携带 rs1799836 A 等位基因的患者,可能与 MAO-B 活性更高有关,其言语贫乏的严重程度更高,而携带 rs6651806 A 等位基因的患者其阴性症状的严重程度更高。这些发现表明,与 COMT 和 MAO-B 遗传变异相关的多巴胺降解增加与精神分裂症患者阴性症状严重程度的性别特异性增加有关。

相似文献

1
The Associations between COMT and MAO-B Genetic Variants with Negative Symptoms in Patients with Schizophrenia.COMT 和 MAO-B 基因变异与精神分裂症患者阴性症状的关联。
Curr Issues Mol Biol. 2021 Jul 8;43(2):618-636. doi: 10.3390/cimb43020045.
2
[Polymorphisms of catechol-O-methyltransferase and monoamine oxidase B genes among Chinese patients with Parkinson's disease].[中国帕金森病患者儿茶酚-O-甲基转移酶和单胺氧化酶B基因的多态性]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Feb;32(1):1-5. doi: 10.3760/cma.j.issn.1003-9406.2015.01.001.
3
MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease.MAO-B 和 COMT 基因变异与帕金森病患者左旋多巴治疗反应的相关性。
J Clin Pharmacol. 2018 Jul;58(7):920-926. doi: 10.1002/jcph.1096. Epub 2018 Mar 26.
4
Genotypic and Haplotypic Association of Catechol--Methyltransferase rs4680 and rs4818 Gene Polymorphisms with Particular Clinical Symptoms in Schizophrenia.儿茶酚-O-甲基转移酶 rs4680 和 rs4818 基因多态性与精神分裂症特定临床症状的基因型和单倍型关联。
Genes (Basel). 2023 Jun 27;14(7):1358. doi: 10.3390/genes14071358.
5
Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population.中国人群中儿茶酚-O-甲基转移酶和单胺氧化酶B基因多态性与帕金森病运动并发症的关联
Parkinsonism Relat Disord. 2014 Oct;20(10):1041-5. doi: 10.1016/j.parkreldis.2014.06.021. Epub 2014 Jul 4.
6
Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia.儿茶酚-O-甲基转移酶 rs4680 和 rs4818 单倍型与精神分裂症患者奥氮平治疗反应的关联。
Sci Rep. 2020 Jun 22;10(1):10049. doi: 10.1038/s41598-020-67351-5.
7
Preliminary Evidence for an Association Between Variants of the Catechol-O-Methyltransferase (COMT) Gene and Premature Ejaculation.儿茶酚氧位甲基转移酶(COMT)基因变异与早泄相关性的初步证据。
J Sex Med. 2017 Dec;14(12):1558-1565. doi: 10.1016/j.jsxm.2017.11.002.
8
Relationships of Cerebrospinal Fluid Alzheimer's Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms.脑脊液阿尔茨海默病生物标志物与 COMT、DBH 和 MAOB 单核苷酸多态性的关系。
J Alzheimers Dis. 2020;73(1):135-145. doi: 10.3233/JAD-190991.
9
Associations between Catechol-O-methyltransferase (COMT) polymorphisms and cognitive impairments, psychiatric symptoms and tardive dyskinesia in schizophrenia.儿茶酚-O-甲基转移酶(COMT)基因多态性与精神分裂症的认知障碍、精神症状及迟发性运动障碍之间的关联。
Brain Res. 2024 Mar 1;1826:148740. doi: 10.1016/j.brainres.2023.148740. Epub 2023 Dec 22.
10
Haplotypic and Genotypic Association of Catechol--Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia.儿茶酚-O-甲基转移酶rs4680和rs4818多态性与精神分裂症治疗抵抗的单倍型及基因型关联
Front Pharmacol. 2018 Jul 3;9:705. doi: 10.3389/fphar.2018.00705. eCollection 2018.

引用本文的文献

1
Association of Lower COMT Activity Alleles with Aggressive Traits in Male Youth with Conduct Disorder Living in a Correctional Facility.低儿茶酚-O-甲基转移酶(COMT)活性等位基因与生活在教养机构中的患有品行障碍的男性青少年攻击性行为特征的关联。
Biomolecules. 2025 Apr 9;15(4):554. doi: 10.3390/biom15040554.
2
The moderating role of COMT gene rs4680 polymorphism between maladaptive metacognitive beliefs and negative symptoms in patients with schizophrenia.COMT 基因 rs4680 多态性在精神分裂症患者适应不良元认知信念与阴性症状之间的调节作用。
BMC Psychiatry. 2024 Nov 20;24(1):831. doi: 10.1186/s12888-024-06275-0.
3
COMT and Neuregulin 1 Markers for Personalized Treatment of Schizophrenia Spectrum Disorders Treated with Risperidone Monotherapy.COMT 和 Neuregulin 1 标志物可用于预测利培酮单药治疗精神分裂症谱系障碍的个体化疗效。
Biomolecules. 2024 Jun 29;14(7):777. doi: 10.3390/biom14070777.
4
MAOB expression correlates with a favourable prognosis in prostate cancer, and its genetic variants are associated with the metastasis of the disease.MAOB 表达与前列腺癌的良好预后相关,其遗传变异与疾病的转移相关。
J Cell Mol Med. 2024 Apr;28(8):e18229. doi: 10.1111/jcmm.18229.
5
Individual and Combined Effect of / Gene Variants and Adverse Childhood Experiences on the Severity of Major Depressive Disorder.基因变异与童年不良经历对重度抑郁症严重程度的个体及联合影响
Behav Sci (Basel). 2023 Sep 26;13(10):795. doi: 10.3390/bs13100795.
6
A narrative review of the effects of dexamethasone on traumatic brain injury in clinical and animal studies: focusing on inflammation.一项关于地塞米松在临床和动物研究中对创伤性脑损伤影响的叙述性综述:重点关注炎症。
Inflammopharmacology. 2023 Dec;31(6):2955-2971. doi: 10.1007/s10787-023-01361-3. Epub 2023 Oct 16.
7
Genotypic and Haplotypic Association of Catechol--Methyltransferase rs4680 and rs4818 Gene Polymorphisms with Particular Clinical Symptoms in Schizophrenia.儿茶酚-O-甲基转移酶 rs4680 和 rs4818 基因多态性与精神分裂症特定临床症状的基因型和单倍型关联。
Genes (Basel). 2023 Jun 27;14(7):1358. doi: 10.3390/genes14071358.
8
Epigenetic Targets in Schizophrenia Development and Therapy.精神分裂症发展与治疗中的表观遗传靶点
Brain Sci. 2023 Mar 1;13(3):426. doi: 10.3390/brainsci13030426.
9
Gene Expression and Epigenetic Regulation in the Prefrontal Cortex of Schizophrenia.精神分裂症前额叶皮层中的基因表达和表观遗传调控。
Genes (Basel). 2023 Jan 18;14(2):243. doi: 10.3390/genes14020243.
10
The Associations of Neutrophil-Lymphocyte, Platelet-Lymphocyte, Monocyte-Lymphocyte Ratios and Immune-Inflammation Index with Negative Symptoms in Patients with Schizophrenia.中性粒细胞-淋巴细胞、血小板-淋巴细胞、单核细胞-淋巴细胞比值及免疫炎症指数与精神分裂症患者阴性症状的相关性。
Biomolecules. 2023 Feb 4;13(2):297. doi: 10.3390/biom13020297.

本文引用的文献

1
The Pathological Role of Astrocytic MAOB in Parkinsonism Revealed by Genetic Ablation and Over-expression of MAOB.通过单胺氧化酶B(MAOB)的基因消融和过表达揭示星形胶质细胞MAOB在帕金森病中的病理作用。
Exp Neurobiol. 2021 Apr 30;30(2):113-119. doi: 10.5607/en21007.
2
Risk Genes in Schizophrenia and Their Importance in Choosing the Appropriate Antipsychotic Treatment.精神分裂症的风险基因及其在选择合适的抗精神病药物治疗中的重要性。
Curr Pharm Des. 2021 Oct 5;27(30):3281-3292. doi: 10.2174/1381612827666210215151333.
3
Physical and social anhedonia are associated with suicidality in major depression, but not in schizophrenia.躯体快感缺失和社会快感缺失与重性抑郁障碍的自杀意念相关,但与精神分裂症无关。
Suicide Life Threat Behav. 2021 Jun;51(3):446-454. doi: 10.1111/sltb.12724. Epub 2020 Dec 14.
4
2-Phenylethylamine (PEA) Ameliorates Corticosterone-Induced Depression-Like Phenotype via the BDNF/TrkB/CREB Signaling Pathway.苯乙胺(PEA)通过 BDNF/TrkB/CREB 信号通路改善皮质酮诱导的抑郁样表型。
Int J Mol Sci. 2020 Nov 30;21(23):9103. doi: 10.3390/ijms21239103.
5
Detention in Juvenile Correctional Facilities Is Associated with Higher Platelet Monoamine Oxidase B Activity in Males.少年管教所拘留与男性血小板单胺氧化酶 B 活性升高有关。
Biomolecules. 2020 Nov 15;10(11):1555. doi: 10.3390/biom10111555.
6
Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches.单胺氧化酶抑制剂:从经典到新的临床应用方法
Handb Exp Pharmacol. 2021;264:229-259. doi: 10.1007/164_2020_384.
7
Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia.儿茶酚-O-甲基转移酶 rs4680 和 rs4818 单倍型与精神分裂症患者奥氮平治疗反应的关联。
Sci Rep. 2020 Jun 22;10(1):10049. doi: 10.1038/s41598-020-67351-5.
8
Monoamine oxidase B rs1799836 G allele polymorphism is a risk factor for early development of levodopa-induced dyskinesia in Parkinson's disease.单胺氧化酶B rs1799836 G等位基因多态性是帕金森病中左旋多巴诱导的异动症早期发生的一个危险因素。
eNeurologicalSci. 2020 Apr 6;19:100239. doi: 10.1016/j.ensci.2020.100239. eCollection 2020 Jun.
9
Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain.单胺氧化酶线粒体穿梭作用促进多巴胺代谢,从而激活电子传递链。
Nat Neurosci. 2020 Jan;23(1):15-20. doi: 10.1038/s41593-019-0556-3. Epub 2019 Dec 16.
10
Relationships of Cerebrospinal Fluid Alzheimer's Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms.脑脊液阿尔茨海默病生物标志物与 COMT、DBH 和 MAOB 单核苷酸多态性的关系。
J Alzheimers Dis. 2020;73(1):135-145. doi: 10.3233/JAD-190991.